Effect of tiotropium on urinary retention in chronic obstructive pulmonary disease with micturition disorder

Effect of tiotropium on urinary retention in chronic obstructive pulmonary disease with micturition disorder - Effect of tiotropium on urinary retention in COPD with micturition disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001089

Enrollment

Registered

2008-03-19

Start date

2007-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

At the initial visit before the treatment and the visit after 4-week tiotropium administration, lower urinary symptoms and QOL were assessed.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: COPD patients who had been clinically diagnosed with benign prostatic hyperplasia at our institution were enrolled.

Exclusion criteria

Exclusion criteria: Patients with glaucoma, previous bladder or prostate surgery, bladder or prostate cancer, a history of urinary tract infections and serum prostate-specific antigen over 4 ng/ml were excluded.

Design outcomes

Primary

Measure	Time frame
IPSS (International Prostate Symptom Score) QOL index Uroflowmetry	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026